« back

NIHR The Efficacy and Mechanism Evaluation (EME) Programme-Body fluid-based biomarkers in traumatic brain injury

  Tuesday, 22 Aug 2023 | Funding Deadline

The Efficacy and Mechanism Evaluation (EME) Programme and Health Technology Assessment (HTA) Programme are accepting Stage 1 applications to this cross programme call. NIHR interested in proposals which aim to utilise body fluid-based (blood, saliva or cerebrospinal fluid) biomarkers to improve the diagnosis, prognosis and/or management of traumatic brain injury. Applicants should clearly define and justify their choice of marker(s), patient group(s), study design and outcome measures. Primary research including randomised and observational studies will be considered by either programme and evidence syntheses will be considered by HTA. NIHR is seeking studies of biomarkers with a sufficient prior evidence base in a clinical setting and in humans, with the potential to positively impact clinical practice.

Deadline for proposals: 22 August 2023
Find out more here